<DOC>
	<DOCNO>NCT02891343</DOCNO>
	<brief_summary>The early assessment new symptomatic drug Alzheimer disease remain difficult lack predictive end-point . The use battery include different parameter could improve early development . In healthy volunteer , test reverse effect symptomatic drug , necessary induce transient reversible cognitive impairment cerebral activity change challenge test . In context , transient hypoxia could relevant .</brief_summary>
	<brief_title>Effect Hypoxia Cognitive Assessment Cerebral Activity Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Anoxia</mesh_term>
	<criteria>Good health basis medical interview , physical examination standard biology parameter . RightHanded Nonsmoker No cardiac pulmonary pathology No use chronic treatment psychotropic drug substance BMI inferior 25 Kg/m2 French speaker able understand test instruction Informed consent form sign 1 . Subject history current brain disease ( severe brain trauma , transient ischemic attack , stroke , epilepsy , cerebral tumor… ) retinal pathology ( include familial DMLA ) 2 . Subject history Acute Mountain Sickness , High Altitude Cerebral Edema High Altitude Pulmonary Edema 3 . Subject major medical surgical history include coronaropathy pulmonary arterial hypertension 4 . Subject current chronic disease 5 . Subject vascular metabolic risk factor 6 . Subject history current mental disease addiction ( MINI ) 7 . Subject significant abnormality biology 8 . Subject significant abnormality ECG 9 . Subject significant abnormality MRI 10 . Subject significant abnormality electrical activity EEG 11 . Subject family history young onset dementia 12 . Subject family history cardiac pulmonary pathology 13 . Subject family history chronic severe neurological mental disease ( first degree relative ) 14 . Subject claustrophobia contraindication MRI 15 . Subject guardianship 16 . Subject cover Social Security 17 . Subject participate another clinical trial 18 . Subject anxiety ( STAITrait Score T &gt; 51 ) neuroticism personality ( EPI Score N ≥13 ) 19 . Subject beard refusing shave</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cognitive Function</keyword>
	<keyword>Hypoxia</keyword>
	<keyword>Neurophysiological Function</keyword>
	<keyword>Effect Alzheimer Disease symptomatic drug</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>